Pazopanib (P) or placebo in completely resected stage I NSCLC patients: Survival results of the phase II trial IFCT-0703.

被引：0
|
作者：
Besse, Benjamin
Mazieres, Julien
Ribassin-Majed, Laureen
Barlesi, Fabrice
Bennouna, Jaafar
Gervais, Radj
Moreau, Lionel
Berard, Henri
Debieuvre, Didier
Molinier, Oliver
Moro-Sibilot, Denis
Souquet, Pierre Jean
Pignon, Jean-Pierre
Amour, Elodie
Celebic, Aljosa
Morin, Franck
Milleron, Bernard
Zalcman, Gerard
Soria, Jean-Charles
机构：
[1] Gustave Roussy, Villejuif, France
[2] CHU Toulouse, Hop Larrey, Toulouse, France
[3] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France
[4] Inst Cancerol Ouest, Nantes, France
[5] Inst Baclesse, Caen, France
[6] Ctr Hosp Pneumol Colmar, Colmar, France
[7] Hop Instruct Armes St Anne, Toulon, France
[8] Emile Muller Hosp, Mulhouse, France
[9] Le Mans Reg Hosp, Le Mans, France
[10] Grenoble Univ Hosp, Grenoble, France
[11] Lyon Sud Hosp, Acute Resp Med & Thorac Oncol Dept, Pierre Benite, France
[12] Lyon Univ, Inst Canc, Lyon Univ Hosp, Pierre Benite, France
[13] IFCT, Paris, France
[14] Inst Gustave Roussy, Villejuif, France
[15] Intergrp Francophone Cancerol Thorac, Paris, France
[16] Caen Univ Hosp, Caen, France
[17] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7510
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Updated Results of a Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III NSCLC
    Durm, G.
    Althouse, S.
    Sadiq, A.
    Jalal, S.
    Jabbour, S.
    Zon, R.
    Kloecker, G.
    Fisher, W.
    Reckamp, K.
    Kio, E.
    Langdon, R.
    Adesunloye, B.
    Gentzler, R.
    Hanna, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S321 - S321
  • [22] Long-term survival results of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: A multicenter phase II trial (JCOG 0703).
    Nakamori, Mikihito
    Katai, Hitoshi
    Mizusawa, Junki
    Nakamura, Kenichi
    Hiki, Naoki
    Yoshikawa, Takaki
    Kojima, Kazuyuki
    Imamoto, Haruhiko
    Ninomiya, Motoki
    Kitano, Seigo
    Sasako, Mitsuru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer
    Kawamura, Masafumi
    Eguchi, Keisuke
    Izumi, Yotaro
    Yamato, Yasushi
    Koike, Teruaki
    Sakaguchi, Hirozo
    Hada, Enjo
    Kobayashi, Koichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 495 - 501
  • [24] TARGET: A Phase II Study of 5-year Adjuvant Osimertinib in Completely Resected EGFR-mutated Stage II-IIIB NSCLC
    Soo, R.
    De Marinis, F.
    Han, J. -Y.
    Ho, C. M. J.
    Lin, Y.
    Servidio, L.
    Sandelin, M.
    Popat, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S272 - S272
  • [25] Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC)
    Vincent, M. D.
    Butts, C.
    Seymour, L.
    Ding, K.
    Graham, B.
    Twumasi-Ankrah, P.
    Gandara, D.
    Schiller, J.
    Green, M.
    Shepherd, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] A phase II study of GW786034 (pazopanib) in patients with recurrent or metastatic invasive breast carcinoma: Results after completion of stage I: A trial of the Princess Margaret Hospital Phase II Consortium
    Taylor, S. K.
    Chia, S.
    Dent, S.
    Clemons, M.
    Grenci, P.
    Wang, L.
    Oza, A. M.
    Ivy, P.
    Pritchard, K.
    Leighl, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)
    Rosell, R
    de Lena, M
    Carpagnano, F
    Ramlau, R
    Gonzalez-Larriba, J
    Grodzki, T
    Le Groumellec, A
    Aubert, D
    Gasmi, J
    Douillard, J
    LUNG CANCER, 2005, 49 : S3 - S4
  • [28] A Phase I/II Trial of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma
    Reardon, David A.
    Groves, Morris D.
    Wen, Patrick Y.
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Raizer, Jeffrey
    Barriuso, Jorge
    McLendon, Roger E.
    Suttle, A. Benjamin
    Ma, Bo
    Curtis, C. Martin
    Dar, Mohammed M.
    de Bono, Johann
    CLINICAL CANCER RESEARCH, 2013, 19 (04) : 900 - 908
  • [29] Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
    Ma, Sung Jun
    Oladeru, Oluwadamilola T.
    Miccio, Joseph A.
    Iovoli, Austin J.
    Hermann, Gregory M.
    Singh, Anurag K.
    JAMA NETWORK OPEN, 2019, 2 (08)
  • [30] ADJUVANT CISPLATINUM-DOCETAXEL CHEMOTHERAPY IN STAGE IB-II RESECTED NSCLC PATIENTS: THE TOLEDO TRIAL
    Bosquee, L.
    Germonprez, P.
    Aerts, J.
    Peters, F.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S52 - S53
12345